Bruce G Pollock Selected Research

Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)

12/2004

Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce G Pollock Research Topics

Disease

39	Schizophrenia (Dementia Praecox) 01/2022 - 11/2002
31	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 12/2004
31	Cognitive Dysfunction 12/2023 - 03/2003
30	Dementia (Dementias) 02/2024 - 03/2002
14	Major Depressive Disorder (Major Depressive Disorders) 10/2023 - 01/2003
12	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 03/2002
7	Mental Disorders (Mental Disorder) 01/2021 - 12/2008
6	Anxiety Disorders (Anxiety Disorder) 03/2013 - 12/2003
5	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 02/2004
5	Frontotemporal Dementia (Semantic Dementia) 12/2023 - 01/2011
4	Stroke (Strokes) 05/2017 - 01/2008
4	Delirium 09/2011 - 01/2002
4	Hepatitis C 07/2010 - 01/2004
3	Hallucinations (Hallucination) 01/2019 - 03/2002
3	Body Weight (Weight, Body) 02/2016 - 08/2007
3	Mood Disorders (Mood Disorder) 07/2010 - 03/2003
3	Sleep Deprivation 01/2009 - 09/2002
3	Hypertension (High Blood Pressure) 07/2008 - 02/2006
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2023 - 06/2012
2	Parkinson Disease (Parkinson's Disease) 12/2023 - 01/2007
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2021
2	COVID-19 01/2021 - 01/2020
2	Amyloid Plaque 11/2019 - 01/2007
2	Agnosia (Visual Agnosia) 11/2017 - 09/2011
2	Hyperprolactinemia 12/2016 - 08/2013
2	Treatment-Resistant Schizophrenia 08/2014 - 09/2011
2	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2011 - 09/2006
2	Fatigue 07/2010 - 01/2009
2	Psychomotor Agitation (Akathisia) 02/2009 - 02/2007
2	Heart Diseases (Heart Disease) 07/2008 - 03/2006
2	Vascular Diseases (Vascular Disease) 08/2007 - 06/2004
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2007 - 02/2006
2	Depressive Disorder (Melancholia) 04/2007 - 11/2004
2	Hyponatremia 02/2004 - 09/2003
1	Tobacco Use Disorder (Nicotine Dependence) 01/2022
1	Brain Diseases (Brain Disorder) 12/2021
1	Memory Disorders (Memory Loss) 11/2017
1	Cerebral Infarction 04/2016

Drug/Important Bio-Agent (IBA)

23	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 03/2002
23	Citalopram FDA LinkGeneric 10/2019 - 03/2002
22	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022 - 12/2004
11	Olanzapine (Zyprexa)FDA Link 01/2022 - 12/2004
11	Cholinergic Antagonists (Anticholinergics)IBA 12/2021 - 12/2004
11	Antidepressive Agents (Antidepressants)IBA 11/2016 - 09/2002
11	Paroxetine (Paxil)FDA LinkGeneric 01/2009 - 01/2002
9	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2010
9	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2016 - 03/2002
8	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2022 - 12/2009
8	Dopamine (Intropin)FDA LinkGeneric 12/2016 - 04/2009
6	Clozapine (Clozaril)FDA LinkGeneric 01/2021 - 06/2009
6	Escitalopram FDA Link 11/2019 - 01/2009
5	Cholinergic Agents (Cholinergics)IBA 01/2021 - 09/2011
5	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2014 - 09/2004
4	Amyloid (Amyloid Fibrils)IBA 11/2019 - 01/2016
4	ProlactinIBA 09/2015 - 02/2006
3	norclozapineIBA 01/2021 - 01/2012
3	ApolipoproteinsIBA 01/2021 - 06/2004
3	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 09/2002
3	BenzodiazepinesIBA 11/2016 - 12/2003
3	RacloprideIBA 10/2014 - 04/2009
3	Memantine (Namenda)FDA Link 03/2013 - 01/2011
3	Interferon-alpha (Interferon Alfa)IBA 07/2010 - 02/2009
3	Serotonin (5 Hydroxytryptamine)IBA 12/2008 - 02/2004
2	Apolipoprotein E4IBA 02/2024 - 12/2003
2	Amyloid beta-PeptidesIBA 12/2023 - 10/2023
2	Apolipoproteins E (ApoE)IBA 01/2021 - 06/2012
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 01/2019
2	Inosine Monophosphate (IMP)IBA 04/2019 - 05/2017
2	ziprasidone (Geodon)FDA Link 03/2014 - 11/2011
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2011 - 01/2008
2	Perphenazine (Trilafon)FDA LinkGeneric 01/2010 - 03/2002
2	LipidsIBA 07/2008 - 02/2006
2	Nortriptyline (Aventyl)FDA LinkGeneric 02/2007 - 03/2003
2	SodiumIBA 02/2004 - 09/2003
1	Glial Fibrillary Acidic ProteinIBA 12/2023
1	LipopolysaccharidesIBA 10/2023
1	lipopolysaccharide-binding proteinIBA 10/2023
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 01/2023
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Nicotine FDA Link 01/2022
1	VaccinesIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2021
1	Cholinergic ReceptorsIBA 01/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021
1	hydroxide ionIBA 01/2021
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 11/2019
1	Fluorine-18IBA 11/2017
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 05/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2016
1	Lorazepam (Ativan)FDA LinkGeneric 05/2016
1	Therapeutic UsesIBA 05/2016

Therapy/Procedure

8	Transcranial Direct Current Stimulation 12/2023 - 01/2019
8	Drug Therapy (Chemotherapy) 01/2016 - 03/2002
5	Therapeutics 11/2009 - 01/2004
4	Long-Term Care 01/2022 - 12/2006
3	Activities of Daily Living (ADL) 12/2023 - 11/2017
3	Drug Tapering 10/2016 - 10/2014
2	Transcranial Magnetic Stimulation 11/2021 - 09/2011
1	Polypharmacy 11/2017